Found 0 matching trials
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings PHASE3 CanTreatCOVID is an open-label, individually randomized, multi-centre, nati...
Show More Status
Active Not Recruiting
Location
The Governors of the University of Calgary
Learn More & Join Trial
A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19 N/A The purpose of this post marketing observational study is to learn about th...
Show More Location
Pfizer Local County
Learn More & Join Trial
Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332 PHASE1 The study is to estimate the effect of hepatic impairment on the plasma PK ...
Show More Location
Orange County Research Center
Learn More & Join Trial
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) PHASE2 The trial will develop and validate a platform for quantitative assessment ...
Show More Location
Universidade Federal de Minas Gerais
Learn More & Join Trial
A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe N/A The purpose of this study is to understand how COVID-19 affects people's ab...
Show More Learn More & Join Trial
Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir N/A Nirmatrelvir-ritonavir is approved for coronavirus disease 2019 (COVID-19) ...
Show More Location
Prince of Wales Hospital, Chinese University of Hong Kong
Learn More & Join Trial
Paxlovid for Treatment of Long Covid PHASE2 The purpose of this study is to compare whether being treated with nirmatre...
Show More Location
Stanford University
Learn More & Join Trial
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients N/A The primary objective of the study was to assess the appropriateness of ant...
Show More Learn More & Join Trial
Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population PHASE3 This is open-labe randomized multicenter comparative Phase III study conduc...
Show More Location
Regional Budgetary Healthcare Institution "Ivanovo Clinical Hospital"
Learn More & Join Trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia PHASE3 REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Show More Location
University of Florida
Learn More & Join Trial